Semaglutide found to reduce inflammation, scarring in people with severe form of fatty liver disease
(Newser) -
Experts exploring what other conditions semaglutide, the active ingredient in Wegovy and Ozempic, might help apart from diabetes and weight loss say the results of a Phase 3 clinical trial suggest it may reverse a common liver disease. Some 15 million US adults have metabolic dysfunction-associated steatohepatitis (MASH), an advanced...